510 related articles for article (PubMed ID: 7859582)
1. Optimizing acid suppression for treatment of acid-related diseases.
Hunt RH; Cederberg C; Dent J; Halter F; Howden C; Marks IN; Rune S; Walt RP
Dig Dis Sci; 1995 Feb; 40(2 Suppl):24S-49S. PubMed ID: 7859582
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
3. Is there any acid peptic disease that is refractory to proton pump inhibitors?
Bardhan KD
Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
[TBL] [Abstract][Full Text] [Related]
4. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
Jones DB; Howden CW; Burget DW; Kerr GD; Hunt RH
Gut; 1987 Sep; 28(9):1120-7. PubMed ID: 2890561
[TBL] [Abstract][Full Text] [Related]
5. Appropriate acid suppression in the treatment of acid-related conditions.
Howden CW
Pharmacol Ther; 1994; 63(1):123-34. PubMed ID: 7972343
[TBL] [Abstract][Full Text] [Related]
6. Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease.
Howden CW; Burget DW; Hunt RH
Scand J Gastroenterol Suppl; 1994; 201():79-82. PubMed ID: 8047830
[TBL] [Abstract][Full Text] [Related]
7. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
8. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
9. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
10. Acid suppression therapy: where do we go from here?
Scarpignato C; Pelosini I; Di Mario F
Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
[TBL] [Abstract][Full Text] [Related]
11. The rationale of acid suppression in the treatment of acid-related disease.
Mohamed AH; Hunt RH
Aliment Pharmacol Ther; 1994; 8 Suppl 1():3-10. PubMed ID: 7910047
[TBL] [Abstract][Full Text] [Related]
12. Optimizing the pharmacology of acid control in acid-related disorders.
Howden CW
Am J Gastroenterol; 1997 Apr; 92(4 Suppl):17S-19S; discussion 19S-21S. PubMed ID: 9127622
[TBL] [Abstract][Full Text] [Related]
13. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
[TBL] [Abstract][Full Text] [Related]
14. The correlation between acid suppression and peptic ulcer healing.
Hunt RH; Howden CW; Jones DB; Burget DW; Kerr GD
Scand J Gastroenterol Suppl; 1986; 125():22-31. PubMed ID: 3469740
[TBL] [Abstract][Full Text] [Related]
15. pH, healing rate and symptom relief in acid-related diseases.
Huang JQ; Hunt RH
Yale J Biol Med; 1996; 69(2):159-74. PubMed ID: 9112748
[TBL] [Abstract][Full Text] [Related]
16. [Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease].
Ivanov AN; Iakovenko EP; Iakovenko AV
Eksp Klin Gastroenterol; 2004; (4):16-20, 107. PubMed ID: 15568661
[TBL] [Abstract][Full Text] [Related]
17. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.
Stedman CA; Barclay ML
Aliment Pharmacol Ther; 2000 Aug; 14(8):963-78. PubMed ID: 10930890
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the therapeutic effects and acid suppression of H2-receptor antagonist and proton pump inhibitor in patients with gastric body ulcer--a prospective controlled trial].
Takeyama Y; Matsui T; Yao T; Motomura A; Arita M; Okada M; Tanaka K; Imamura T; Hatakeyama S
Nihon Shokakibyo Gakkai Zasshi; 1999 May; 96(5):502-10. PubMed ID: 10368993
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological control of gastric acid secretion.
Zfass AM; McHenry L; Sanyal AJ
Gastroenterologist; 1993 Mar; 1(1):83-7. PubMed ID: 8049882
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
